Breaking News, Collaborations & Alliances

CMIC Supports Avigan Production for Potential COVID-19 Treatment

Includes clinical trials and manufacturing of influenza antiviral drug for COVID-19 patients

By: Contract Pharma

Contract Pharma Staff

CMIC Holdings Co., Ltd. said its affiliate, CMIC Co., Ltd., a contract research organization (CRO) in Japan, is providing monitoring services for Avigan Tablet (favipiravir), a product that Fujifilm Toyama Chemical Co., Ltd. gained approval in Japan for manufacture and sale as an influenza antiviral drug, phase III clinical trial in Japan and will support for manufacturing the product as a contract development and manufacturing organization (CDMO).   Recently, Fujifilm announced the start of cli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters